Activation of anti-tumor immune response and reduction of regulatory T cells with Mycobacterium indicus pranii (MIP) therapy in tumor bearing mice.
about
Synergistic activation of innate and adaptive immune mechanisms in the treatment of gonadotropin-sensitive tumorsMycobacterium indicus pranii induces dendritic cell activation, survival, and Th1/Th17 polarization potential in a TLR-dependent mannerThe quantum of initial transformed cells potentially modulates the type of local inflammation mechanism elicited by surrounding normal epithelial tissues and systemic immune pattern for tumor arrest or progression.Gonadotropin-mediated chemoresistance: Delineation of molecular pathways and targetsTrial Watch: Experimental Toll-like receptor agonists for cancer therapyMassive gene acquisitions in Mycobacterium indicus pranii provide a perspective on mycobacterial evolution.Nanocarrier-based immunotherapy in cancer management and research.A key role of GARP in the immune suppressive tumor microenvironment.Immunodominant protein MIP_05962 from Mycobacterium indicus pranii displays chaperone activity.Cytotoxic and apoptotic effects of heat killed Mycobacterium indicus pranii (MIP) on various human cancer cell linesMycobacterium indicus pranii and Mycobacterium bovis BCG lead to differential macrophage activation in Toll-like receptor-dependent manner.Mycobacterium indicus pranii (Mw) inhibits invasion by reducing matrix metalloproteinase (MMP-9) via AKT/ERK-1/2 and PKCα signaling: A potential candidate in melanoma cancer therapy.
P2860
Q27324860-357382BF-7750-4BBB-802A-36F28B9B1AEEQ33816748-5033DE63-2AE9-4420-8F5D-70D120338F94Q34791671-ABCB5367-DA77-4441-B588-7EEBD4264361Q35853333-09FC78DB-1264-4B3E-ABA6-705D1BB9B0A4Q36194849-A4B2050F-EDFC-4B8E-BDDC-508ECF9C219EQ36422227-7A98F422-20E0-4B92-977A-DA115E224CB6Q37031671-D7ABAA81-3952-4A92-9576-6B556CC15FE0Q39985213-FA0F1239-B746-4A10-B942-E061ABBD8AB1Q40293298-B7E9FE5D-68B5-4D0B-A613-DD1C0062F67DQ41832204-3EA1F512-A0AE-438B-B6C0-6508F5AB0B78Q46901600-DD0F93A0-FC3B-49C3-BE72-5BB6DC9D258BQ47139300-EE225633-5220-4663-AAFD-7D555F52A7CD
P2860
Activation of anti-tumor immune response and reduction of regulatory T cells with Mycobacterium indicus pranii (MIP) therapy in tumor bearing mice.
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Activation of anti-tumor immun ...... therapy in tumor bearing mice.
@ast
Activation of anti-tumor immun ...... therapy in tumor bearing mice.
@en
Activation of anti-tumor immun ...... h Mycobacterium indicus pranii
@nl
type
label
Activation of anti-tumor immun ...... therapy in tumor bearing mice.
@ast
Activation of anti-tumor immun ...... therapy in tumor bearing mice.
@en
Activation of anti-tumor immun ...... h Mycobacterium indicus pranii
@nl
prefLabel
Activation of anti-tumor immun ...... therapy in tumor bearing mice.
@ast
Activation of anti-tumor immun ...... therapy in tumor bearing mice.
@en
Activation of anti-tumor immun ...... h Mycobacterium indicus pranii
@nl
P2093
P2860
P1433
P1476
Activation of anti-tumor immun ...... therapy in tumor bearing mice
@en
P2093
Pawan Kumar
Pramod Upadhyay
Seenu Haridas
P2860
P304
P356
10.1371/JOURNAL.PONE.0025424
P407
P577
2011-09-30T00:00:00Z